abstract |
The present invention relates to a method for screening a compound that inhibits cell binding of HCV, a method for inhibiting cell entry of HCV, and a method for positively or prophylactically treating HCV infection. Each method is based on the identification of scavenger receptor class B type I as the target site for cell binding of HCV E2. |